Semaglutide Functions primarily as a GLP-1 receptor agonist Helps regulate appetite and satiety Widely used in medical weight-loss programs Tirzepatide Targets both GLP-1 and GIP pathways Provides dual hormone activity May produce greater average weight loss in some patients The best option depends on several factors, including medical history, treatment goals, medication tolerance, and provider recommendations
The procedures change the production of gut hormones that control hunger, fullness, and blood sugar regulation
Secondly, it acts on the brains reward system, reducing cravings and the desire to eat high-calorie foods
Healthy Fats Fats like monounsaturated fatty acids (MUFA) and omega-3s can increase GLP-1 levels
So there are a number of things that have been tried, but these medications offer hope in a space where we've had little hope. Young said GLP-1 medications can come with a downside when patients stop taking them after losing weight
In February 2026, Daewoong signed an exclusive global licensing agreement for commercialization